6-24357626-GAC-G
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000378454.8(DCDC2):βc.123_124delβ(p.Ser42GlnfsTer72) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,384 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 32)
Exomes π: 0.000016 ( 0 hom. )
Consequence
DCDC2
ENST00000378454.8 frameshift
ENST00000378454.8 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.16
Genes affected
DCDC2 (HGNC:18141): (doublecortin domain containing 2) This gene encodes a doublecortin domain-containing family member. The doublecortin domain has been demonstrated to bind tubulin and enhance microtubule polymerization. This family member is thought to function in neuronal migration where it may affect the signaling of primary cilia. Mutations in this gene have been associated with reading disability (RD) type 2, also referred to as developmental dyslexia. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-24357626-GAC-G is Pathogenic according to our data. Variant chr6-24357626-GAC-G is described in ClinVar as [Pathogenic]. Clinvar id is 180688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-24357626-GAC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DCDC2 | NM_016356.5 | c.123_124del | p.Ser42GlnfsTer72 | frameshift_variant | 1/10 | ENST00000378454.8 | NP_057440.2 | |
KAAG1 | NR_174942.1 | n.727_728del | non_coding_transcript_exon_variant | 1/1 | ||||
DCDC2 | NM_001195610.2 | c.123_124del | p.Ser42GlnfsTer72 | frameshift_variant | 2/11 | NP_001182539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DCDC2 | ENST00000378454.8 | c.123_124del | p.Ser42GlnfsTer72 | frameshift_variant | 1/10 | 1 | NM_016356.5 | ENSP00000367715 | P1 | |
KAAG1 | ENST00000274766.2 | n.727_728del | non_coding_transcript_exon_variant | 1/1 | ||||||
DCDC2 | ENST00000436313.1 | c.26_27del | p.Ser10GlnfsTer72 | frameshift_variant | 1/3 | 3 | ENSP00000410939 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248076Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134636
GnomAD3 exomes
AF:
AC:
4
AN:
248076
Hom.:
AF XY:
AC XY:
2
AN XY:
134636
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461154Hom.: 0 AF XY: 0.0000179 AC XY: 13AN XY: 726892
GnomAD4 exome
AF:
AC:
23
AN:
1461154
Hom.:
AF XY:
AC XY:
13
AN XY:
726892
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
GnomAD4 genome
AF:
AC:
1
AN:
152230
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Isolated neonatal sclerosing cholangitis Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center | Mar 14, 2024 | This sequence variant is a 2 nucleotide deletion (delGT) in the exon 1 of 10 of the DCDC2 gene that results in an early termination codon 72 amino acids downstream of the frameshift at codon 42. This variant is predicted to generate a non-functional allele through either the expression of a truncated protein or a loss of doublecortin domain containing 2 expression due to nonsense mediated decay. This is a previously reported variant (ClinVar 180688) that has been observed in both homozygous and compound heterozygous states in individuals affected by hepatic ciliopathy and neonatal sclerosing cholangitis (PMID: 25557784, 37296768, 27469900, 36938759). This variant is present in 5 of 400306 alleles (0.0012%) in the gnomAD population dataset. Functional studies have found that the protein resulting from this variant failed to properly localize in the primary cilium, did not interact with its protein partners, and could not rescue mouse kidney cells in which DCDC2 expression was knocked-down (PMID: 25557784). Based upon the evidence, we consider this variant to be pathogenic. ACMG Criteria: PM2, PS3, PVS1 - |
Autosomal recessive nonsyndromic hearing loss 66;C4479344:Isolated neonatal sclerosing cholangitis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 22, 2022 | This sequence change creates a premature translational stop signal (p.Ser42Glnfs*72) in the DCDC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DCDC2 are known to be pathogenic (PMID: 27319779, 27469900). This variant is present in population databases (rs757704417, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with DCDC2-related conditions (PMID: 25557784, 27469900). ClinVar contains an entry for this variant (Variation ID: 180688). For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive nonsyndromic hearing loss 66;C4015542:Nephronophthisis 19;C4479344:Isolated neonatal sclerosing cholangitis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 11, 2022 | - - |
Nephronophthisis 19 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2015 | - - |
Dyslexia, susceptibility to, 2 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 20, 2018 | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at